Effects of different doses of dexamethasone plus flunixin meglumine on survival rate in lethal endotoxemia

Acta Veterinaria

Volumn 59, Issue 1, 2009, Pages 47-51

  Er, A ^a   Uney, K ^a   Altan, F ^b   Cetin, G ^a   Yazar, E ^a   Elmas, M ^a  

^a SELCUK UNIVERSITY   (Turkey)

^b DICLE UNIVERSITY   (Turkey)

Author keywords

Dexamethasone; Flunixin; Lethal endotoxaemia; Survival rate

Indexed keywords

ANIMALIA; MUS;

EID: 64549148455     PISSN: 05678315     EISSN: None     Source Type: Journal    
DOI: 10.2298/AVB0901047E     Document Type: Article

References (20)

1. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y, 2004, Corticosteroids for severe sepsis and septic shock: a systemic review and meta-analysis, BMJ, 329,480-4.
2. Bryant CE, Farnfield BA, Janicke HJ, 2003, Evaluation of the ability of carprofen and flunixin meglumine to inhibit activation of nuclear factor kappa B, Am J Vet Res, 64, 211-5.
3. Ewert KM, Fessler JF, Templeton CB, Bottoms GD, Latshaw HS, Jhonson MA, 1985, Endotoxin-induced hematologic and blood chemical changes in ponies: Effects of flunixin meglumine, dexamethasone and prednisolone, Am J Vet Res, 46, 24-30.
4. Furr M, 2003, Systemic inflammatory response syndrome, sepsis and antimicrobial therapy, Clin Tech Equin Pract, 2, 3-8.
5. Keh D, Feldheiser A, Ahlers O, 2005, Current state of corticosteroid therapy in patients with septic shock, Clinical Intensive Care, 16,151-61.
6. Konyalioglu S, Er A, Uney K, Elmas M, Yazar E, 2007, Effect of flunixin meglumine on the antioxidant status in endotoxemia, Acta Vet Beograd, 57, 241-6.
7. Kumar A, Mann HJ, 2004, Appraisal of four novel approaches to the prevention and treatments of sepsis, Am J Vet Res, 61, 765-76.
8. Margolis JH, Bottoms GD, Fessler JF, 1987, The efficacy of dexamethasone and flunixin meglumine in treating endotoxin-induced changes in calves, Vet Res Commun, 11,479-91.
9. Meduri GU, 1999, An historical review of glucocorticoid treatment in sepsis. Disease pathophysiology and the design of treatment investigation, Sepsis, 3, 21-38.
10. Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C, 2004, Meta-analysis: The effect of steroids on survival and shock during sepsis depends on the dose, Ann Intern Med, 141,47-56.
11. Otto CM, 2007, Clinical trials in spontaneous disease in dogs: a new paradigm for investigations of sepsis, J Vet Emerg Clin Care, 17, 359-67.
12. Sanchez LC, 2005, Equine neonatal sepsis, Vet Clin Equine, 21, 273-93.
13. Servansky J, Natanson C, 2000, Clinical trials in sepsis: an update. Curt Opin Anaesthesiol, 13,125-9.
14. Smith GW, 2005, Supportive therapy of the toxic cow, Vet Clin Food Anim, 21, 595-614.
15. Wang Z, Kang J, Li Y, Yuan Z, Liu S, Sun L, 2006, The effects of dexamethasone on rat brain cortical nuclear factor kappa B (NF-kB) in endotoxic shock, Toxicol Appl Pharm, 214, 263-9.
16. Wu CC, 2006, Possible therapies of septic shock: Based on animal studies and clinical trials, Curr Pharm Design, 12, 3535-41.
17. Vincent JL, 2008, Steroids in sepsis: another swing of the pendulum in our clinical trials, Crit Care, 12,1-2.
18. Yazar E, Konyalioglu S, Col R, Birdane YO, Bas AL, Elmas M, 2004a, Effects of vitamin E and prednisolone on some oxidative stress markers in endotoxemic rabbits, Revue Med Vet, 155, 538-42.
19. Yazar E, Col R, Konyalioglu S, Birdane YO, Elmas M, Bas AL, 2004b, Effects of vitamin E and prednisolone on biochemical and haematological parameters in endotoxaemic New Zealand White rabbits, Bull Vet Inst Pulawy, 48,105-8.
20. Yazar E, Er A, Uney K, Altunok V, Elmas M, 2007, Effect of flunixin meglumine on cytokine levels in experimental endotoxemia in mice, J Vet Med A, 54, 352-5.